Literature DB >> 20639480

c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74.

Maya Gordin1, Melania Tesio, Sivan Cohen, Yael Gore, Frida Lantner, Lin Leng, Richard Bucala, Idit Shachar.   

Abstract

The signals regulating the survival of mature splenic B cells have become a major focus in recent studies of B cell immunology. Durable B cell persistence in the periphery is dependent on survival signals that are transduced by cell surface receptors. In this study, we describe a novel biological mechanism involved in mature B cell homeostasis, the hepatocyte growth factor/scatter factor (HGF)/c-Met pathway. We demonstrate that c-Met activation by HGF leads to a survival cascade, whereas its blockade results in induction of mature B cell death. Our results emphasize a unique and critical function for c-Met signaling in the previously described macrophage migration inhibitory factor/CD74-induced survival pathway. Macrophage migration inhibitory factor recruits c-Met to the CD74/CD44 complex and thereby enables the induction of a signaling cascade within the cell. This signal results in HGF secretion, which stimulates the survival of the mature B cell population in an autocrine manner. Thus, the CD74-HGF/c-Met axis defines a novel physiologic survival pathway in mature B cells, resulting in the control of the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639480      PMCID: PMC3646513          DOI: 10.4049/jimmunol.0902566

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  Requirement for invariant chain in B cell maturation and function.

Authors:  I Shachar; R A Flavell
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

2.  Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor.

Authors:  R Wang; R Kobayashi; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.

Authors:  R Lazova; R Moynes; D May; G Scott
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

4.  Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud.

Authors:  F Bladt; D Riethmacher; S Isenmann; A Aguzzi; C Birchmeier
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

5.  Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins.

Authors:  I S Weimar; D de Jong; E J Muller; T Nakamura; J M van Gorp; G C de Gast; W R Gerritsen
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

6.  Hepatocyte growth factor and its receptor c-met in multiple myeloma.

Authors:  M Börset; H Hjorth-Hansen; C Seidel; A Sundan; A Waage
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

7.  Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.

Authors:  K Meyer-Siegler; P B Hudson
Journal:  Urology       Date:  1996-09       Impact factor: 2.649

8.  Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization.

Authors:  D Rusciano; P Lorenzoni; M M Burger
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

9.  Lymphoid monoclonal antibodies reactive with lung tumors. Diagnostic applications.

Authors:  H L Ioachim; S E Pambuccian; M Hekimgil; F R Giancotti; B H Dorsett
Journal:  Am J Surg Pathol       Date:  1996-01       Impact factor: 6.394

10.  Hepatocyte growth factor as a hematopoietic regulator.

Authors:  T Nishino; H Hisha; N Nishino; M Adachi; S Ikehara
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

View more
  21 in total

1.  The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.

Authors:  Sivan Cohen; Or-yam Shoshana; Einat Zelman-Toister; Nitsan Maharshak; Inbal Binsky-Ehrenreich; Maya Gordin; Inbal Hazan-Halevy; Yair Herishanu; Lev Shvidel; Michal Haran; Lin Leng; Richard Bucala; Sheila Harroch; Idit Shachar
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Reduced T cell-dependent humoral immune response in microsomal prostaglandin E synthase-1 null mice is mediated by nonhematopoietic cells.

Authors:  Fumiaki Kojima; Andrey Frolov; Rahul Matnani; Jerold G Woodward; Leslie J Crofford
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

3.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

Review 4.  Midkine as a regulator of B cell survival in health and disease.

Authors:  Sivan Cohen; Idit Shachar
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

5.  CD84 mediates CLL-microenvironment interactions.

Authors:  A Marom; A F Barak; M P Kramer; H Lewinsky; I Binsky-Ehrenreich; S Cohen; A Tsitsou-Kampeli; V Kalchenko; Y Kuznetsov; V Mirkin; N Dezorella; M Shapiro; P L Schwartzberg; Y Cohen; L Shvidel; M Haran; S Becker-Herman; Y Herishanu; I Shachar
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

Review 6.  Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa.

Authors:  Kabir A Khan; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2018-02-13       Impact factor: 66.675

Review 7.  Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Joshua B Bilsborrow; Edward Doherty; Pathricia V Tilstam; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2019-08-20       Impact factor: 6.902

8.  Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.

Authors:  Sofia Lourenco; Vitor H Teixeira; Tammy Kalber; Ricardo J Jose; R Andres Floto; Sam M Janes
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

9.  CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.

Authors:  Hadas Lewinsky; Avital F Barak; Victoria Huber; Matthias P Kramer; Lihi Radomir; Lital Sever; Irit Orr; Vita Mirkin; Nili Dezorella; Mika Shapiro; Yosef Cohen; Lev Shvidel; Martina Seiffert; Yair Herishanu; Shirly Becker-Herman; Idit Shachar
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

10.  Hepatocyte growth factor in dampening liver immune-mediated pathology in acute viral hepatitis without compromising antiviral activity.

Authors:  Renan Aguilar-Valenzuela; Eric D Carlsen; Yuejin Liang; Lynn Soong; Jiaren Sun
Journal:  J Gastroenterol Hepatol       Date:  2014-04       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.